AmgenvsFennec Pharmaceuticals

AMGN and FENC stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$435.64

Value $235B

-0.72%
AMGN's page

FENC

Fennec Pharmaceuticals Inc.

$13.09

Value $451M

-2.68%
FENC's page

Amgen (AMGN) has a market value of $235B and Fennec Pharmaceuticals (FENC) $451M. Over the last year, with dividends, AMGN moved +31.5% and FENC +60.0%. The P/E is 25.0 for AMGN and 321.3 for FENC. Dividend yield: AMGN 2.31%, FENC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$235B

    FENC$451M

    AMGN is 520 times FENC

  • Revenue, 12 months

    AMGN$38.9B

    FENC$66M

    AMGN is 586 times FENC

  • Net income, 12 months

    AMGN$9.4B

    FENC$2.0M

    AMGN is 4,631 times FENC

  • Operating margin

    AMGN32.4%

    FENC5.6%

    26.8 points apart

  • ROIC

    AMGN16.2%

    FENC–

  • P/E

    AMGN25.0

    FENC321.3

    FENC is 13 times AMGN

  • Dividend yield

    AMGN2.3%

    FENC0.0%

    2.3 points apart

  • 5-year return

    AMGN+146.3%

    FENC+33.3%

    113.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+146.3%

FENC+33.3%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsFENCWith dividends
1 year since November 19, 2025+31.5%Price +27.2%+60.0%Price +60.0%
3 years since November 20, 2023+79.2%+21.5% a yearPrice +64.2%+53.3%+15.3% a yearPrice +53.3%
5 years since November 19, 2021+146.3%+19.8% a yearPrice +111.4%+33.3%+5.9% a yearPrice +33.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenFENCFennec Pharmaceuticals

Valuation

AMGNFENC
Valuation
Price$435.64$13.09
Market value$235B$451M
Enterprise value (EV)$276B–
P/E25.0321.3
P/E, 5-year median23.0–
P/B16.49.2
EV/EBIT21.9–
Free cash flow yield4.1%0.7%

Results and growth

AMGNFENC
Results and growth
Revenue, 12 months$38.9B$66M
Net income, 12 months$9.4B$2.0M
Free cash flow, 12 months$9.6B$3.1M
Earnings per share, 12 months$17.25$0.04
Revenue growth, year on year10.0%-6.1%
Revenue growth a year, past+7.6%over 5 years+204.7%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNFENC
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%5.6%
Net margin24.1%3.1%
ROIC16.2%–
ROE87.8%6.3%

Balance sheet

AMGNFENC
Balance sheet
Cash$13.2B$49M
Total debt$54.0B–
Net debt / EBITDA2.3–
Interest cover4.8×11.7×

Dividends and buybacks

AMGNFENC
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$10.08–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.3%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or FENC

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Fennec Pharmaceuticals?

By market value, Amgen ($235B) is about 520.4 times Fennec Pharmaceuticals ($451M), at today's prices.

How did AMGN and FENC stock do over the last 5 years?

Since November 19, 2021, AMGN's price moved +111.4% and FENC's +33.3%. With dividends: AMGN +146.3% (+19.8% a year), FENC +33.3% (+5.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or FENC?

The dividend yield at today's price is 2.31% for Amgen and none for Fennec Pharmaceuticals. Over the last twelve months they paid $10.08 and – per share.

What is the P/E of AMGN and FENC?

At today's price, the P/E is 25.0 for AMGN and 321.3 for FENC. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or Fennec Pharmaceuticals?

Over the last twelve months, the net margin was 24.1% for Amgen and 3.1% for Fennec Pharmaceuticals, and the operating margin 32.4% and 5.6%. Revenue was $38.9B and $66M.

Which is the better investment, Amgen or Fennec Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.